Procter & Gamble Company (PG) 83.49 $PG Dow 30 Stock

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Procter & Gamble Company (PG) 83.49 $PG

Dow 30 Stock Roundup: Boeing Wins $276.3M Navy Contract, Cisco to Buy Cloud Startup for $260M
Swarup Gupta - Zacks Investment Research - Fri Mar 04, 2:52PM CST
The Dow continued to gain this week on the back of rising oil prices.
MMM: 160.07 (+0.69), ENDP: 42.44 (-0.73), GE: 30.46 (+0.24), XOM: 82.29 (-0.11), BA: 121.07 (+1.46), JNJ: 106.50 (-0.15), V: 73.90 (-0.01), ADP: 86.19 (+0.54), GS: 156.84 (+1.51), JPM: 60.05 (+0.09), PG: 83.49 (+0.65), CVX: 87.93 (+0.40), MSFT: 52.03 (-0.32), VZ: 51.81 (-0.08), AAPL: 103.01 (+1.51), CSCO: 26.80 (-0.07), BHI: 46.20 (-0.35)

Finding 10% Yields Among The Dividend Champions
Eli Inkrot - at Seeking Alpha - Fri Mar 04, 11:56AM CST

KO: 44.11 (+0.15), JNJ: 106.50 (-0.15), ADM: 37.65 (+0.82), NUE: 42.96 (+0.21), PG: 83.49 (+0.65), BEN: 38.47 (+0.59)

S&P Aristocrats: AbbVie On Top Of An Overbought Index After February
Fredrik Arnold - at Seeking Alpha - Fri Mar 04, 8:37AM CST

KO: 44.11 (+0.15), ABT: 39.18 (+0.36), HCP: 31.50 (+0.12), CLX: 125.61 (+0.02), NUE: 42.96 (+0.21), ED: 71.39 (+0.76), EMR: 51.26 (+0.47), XOM: 82.29 (-0.11), PEP: 100.00 (+0.84), T: 37.93 (-0.06), CINF: 64.52 (+0.02), ADM: 37.65 (+0.82), MCD: 117.18 (+0.49), ABBV: 56.15 (+0.22), DOV: 63.20 (+0.75), PG: 83.49 (+0.65), CVX: 87.93 (+0.40), AFL: 61.03 (+0.05), APD: 134.79 (-0.09)

Domtar: Following The Paper Trail
Timberwolf Equity Research - at Seeking Alpha - Fri Mar 04, 7:45AM CST

CLW: 44.56 (+1.35), UFS: 36.59 (+0.90), KMB: 132.54 (+0.91), PG: 83.49 (+0.65)

P&G Pricing Strength Impressive; Dividend Track Record Equally So
Valuentum - at Seeking Alpha - Fri Mar 04, 12:42AM CST

PG: 83.49 (+0.65)

Professional Investors Will Ruin Your Retirement
Zach Scheidt - Daily Reckoning - Thu Mar 03, 3:49PM CST
This post Professional Investors Will Ruin Your Retirement appeared first on Daily Reckoning . Zach Scheidt shows you how to break free of the Wall Street “groupthink” that’s costing you a fortune and boost your retirement income by 50%... The...
GE: 30.46 (+0.24), PG: 83.49 (+0.65)

5 Reasons to Invest in Kellogg (K) as Sales Improve in 2015
Zacks Equity Research - Zacks Investment Research - Thu Mar 03, 12:30PM CST
Kellogg currently has a Zacks Rank #2 (Buy).
KHC: 77.20 (-0.17), CPB: 61.95 (+0.08), PG: 83.49 (+0.65), K: 75.23 (+0.39)

P&G Sells Hipoglos Diaper Rash Cream to Johnson & Johnson
Zacks Equity Research - Zacks Investment Research - Thu Mar 03, 12:25PM CST
The Procter & Gamble Company (PG) announced that it has divested the Hipoglos diaper rash cream brand in Brazil to a subsidiary of healthcare company, Johnson & Johnson (JNJ).
JNJ: 106.50 (-0.15), COTY: 27.62 (-0.49), KMB: 132.54 (+0.91), PG: 83.49 (+0.65)

The Dividend Aristocrats: Real Time, Real World, Active Investing
David Crosetti - at Seeking Alpha - Thu Mar 03, 11:59AM CST

KO: 44.11 (+0.15), MMM: 160.07 (+0.69), JNJ: 106.50 (-0.15), KMB: 132.54 (+0.91), EMR: 51.26 (+0.47), LOW: 70.39 (+0.46), DOV: 63.20 (+0.75), PG: 83.49 (+0.65), CL: 68.16 (+0.55)

Target and Procter & Gamble tapped as promising dividend plays
Seeking Alpha - at Seeking Alpha - Thu Mar 03, 11:02AM CST

TGT: 81.13 (+1.42), PG: 83.49 (+0.65)

Dividends Don't Drive Total Return They Contribute To It: Part 1
Chuck Carnevale - Seeking Alpha - Thu Mar 03, 10:59AM CST
Introduction I believe there is a critical piece of investment wisdom that all investors in common stocks should possess. Every common stock investor should have a clear understanding of where and how long-term common stock returns are generated...
KO: 44.11 (+0.15), KMB: 132.54 (+0.91), VFC: 65.40 (-0.93), XOM: 82.29 (-0.11), SO: 48.63 (+0.44), PEP: 100.00 (+0.84), JNJ: 106.50 (-0.15), T: 37.93 (-0.06), MCD: 117.18 (+0.49), PG: 83.49 (+0.65), CVX: 87.93 (+0.40), SHW: 276.81 (+4.82), ECL: 106.33 (+1.09)

10 Best Dividend Stocks to Own for Safe Retirement Income
at The Street - Thu Mar 03, 8:47AM CST
The best dividend stocks for retirement offer safe, growing income that you can rely on for years to come.
JNJ: 106.50 (-0.15), CINF: 64.52 (+0.02), PAYX: 52.58 (+0.13), GPC: 93.65 (-0.28), CMI: 102.24 (+0.99), EMR: 51.26 (+0.47), WMT: 66.78 (+0.64), MCD: 117.18 (+0.49), PG: 83.49 (+0.65), FLO: 17.74 (+0.25)

Dogs Of The Dow: It's Intel, Not Caterpillar, Expected To Gain 41% By March 2017
Fredrik Arnold - at Seeking Alpha - Thu Mar 03, 8:18AM CST

AXP: 58.29 (+0.20), NKE: 61.26 (-0.21), UNH: 121.80 (-0.02), PFE: 29.71 (-0.18), XOM: 82.29 (-0.11), BA: 121.07 (+1.46), INTC: 30.63 (+0.05), GS: 156.84 (+1.51), JPM: 60.05 (+0.09), IBM: 137.80 (unch), MRK: 52.08 (-0.02), PG: 83.49 (+0.65), CAT: 72.84 (+1.09), CVX: 87.93 (+0.40), MSFT: 52.03 (-0.32), VZ: 51.81 (-0.08), CSCO: 26.80 (-0.07)

Dividend Growth Portfolio: February Update
The Dividend Bro - at Seeking Alpha - Thu Mar 03, 7:57AM CST

MMM: 160.07 (+0.69), GE: 30.46 (+0.24), XOM: 82.29 (-0.11), O: 58.16 (-0.86), VTR: 56.75 (+0.04), LUV: 41.50 (-0.53), PEP: 100.00 (+0.84), SBUX: 58.70 (-0.34), T: 37.93 (-0.06), JNJ: 106.50 (-0.15), V: 73.90 (-0.01), JPM: 60.05 (+0.09), TGT: 81.13 (+1.42), ABBV: 56.15 (+0.22), MSFT: 52.03 (-0.32), AAPL: 103.01 (+1.51), CSCO: 26.80 (-0.07), MA: 90.05 (+0.31), KO: 44.11 (+0.15), COP: 41.12 (+2.56), MO: 62.98 (+0.75), BA: 121.07 (+1.46), PM: 94.49 (+1.23), GILD: 87.21 (-0.62), CVS: 99.28 (-0.10), PE: 19.50 (+0.97), PG: 83.49 (+0.65), CVX: 87.93 (+0.40), VZ: 51.81 (-0.08), GIS: 60.20 (+0.41), AFL: 61.03 (+0.05)

Did P/E Ratio Or PEG Ratio Predict Total Dividends Paid Or Total Return For These Top 13 Dividend Aristocrats?
Psycho Analyst - at Seeking Alpha - Thu Mar 03, 7:02AM CST

KO: 44.11 (+0.15), KMB: 132.54 (+0.91), VFC: 65.40 (-0.93), XOM: 82.29 (-0.11), SO: 48.63 (+0.44), PEP: 100.00 (+0.84), JNJ: 106.50 (-0.15), T: 37.93 (-0.06), MCD: 117.18 (+0.49), PG: 83.49 (+0.65), CVX: 87.93 (+0.40), SHW: 276.81 (+4.82), ECL: 106.33 (+1.09)

Watch for Procter & Gamble to Potentially Pullback After Gaining 1.63% Yesterday
Comtex SmarTrend(R) - Wed Mar 02, 6:16PM CST
Procter & Gamble (NYSEG) traded in a range yesterday that spanned from a low of $80.85 to a high of $82.66. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $82.65 on volume of 12.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PG: 83.49 (+0.65)

Look for Shares of Procter & Gamble to Potentially Pullback after Yesterday's 1.63% Rise
Comtex SmarTrend(R) - Wed Mar 02, 6:15PM CST
Procter & Gamble (NYSEG) traded in a range yesterday that spanned from a low of $80.85 to a high of $82.66. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $82.65 on volume of 12.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PG: 83.49 (+0.65)

Be Ready When Prices Get Stupid
Ted Waller - at Seeking Alpha - Wed Mar 02, 2:38PM CST

GE: 30.46 (+0.24), XOM: 82.29 (-0.11), WFC: 50.11 (+0.34), PG: 83.49 (+0.65), AAPL: 103.01 (+1.51), CSCO: 26.80 (-0.07), ORCL: 37.89 (unch), HIG: 43.76 (+0.38)

Stocks Down, But Small Caps Up; Gun Stocks Jam Despite Firm Data
at Investor's Business Daily - Wed Mar 02, 2:06PM CST
U.S. stock indexes struggled Wednesday afternoon as only small caps kept to the upside. The Nasdaq trimmed 0.2%, while the S&P 500 and the Dow Jones industrial average were flat and down 0.1% respectively. However, the small-cap Russell 2000 rose...
PG: 83.49 (+0.65), RGR: 73.39 (+1.17), SWHC: 27.05 (+1.65)

Will Helen of Troy (HELE) Gain from Hydro Flask Acquisition?
Zacks Equity Research - Zacks Investment Research - Wed Mar 02, 12:40PM CST
Helen of Troy (HELE) has been consistently making strategic acquisitions, especially in profitable categories, to boost its portfolio.
HELE: 97.98 (+1.58), COTY: 27.62 (-0.49), FRAN: 18.51 (+0.23), PG: 83.49 (+0.65)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Truss Financial Tackles Home Equity Closing Delays

Updated Category News Views 23

Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...

Continue Reading
ROKFORM’s Signal Card: A Wallet Tracker for All

Updated Category News Views 11

The Gadget You Didn't Know You Needed Ever feel that momentary panic when your wallet seems to have vanished into thin air? ROKFORM's fresh offering, the Signal Card, tackles that heart-stopping moment head-on. They've taken the mundane act of misplacing your wallet and transformed it with their sleek, credit-card-sized tracker. This baby pairs seamlessly with Apple Find...

Continue Reading
Charter Next Generation Unveils Gen 2 MDO-PE Films

Updated Category News Views 14

Peering Into CNG's Latest Innovation Charter Next Generation (CNG) just threw down a hefty gauntlet with its launch of next-gen machine-direction-oriented polyethylene (MDO-PE) solutions. They're pushing the envelope on what recycle-ready packaging can do, folks. Let's not mince words—other players in the field better have their game faces on. This ain't just another...

Continue Reading
Cala Launches Game-Changer Wearable for Tremor Relief

Updated Category News Views 13

Breaking New Ground in Neuromodulation Medical tech's on a roll, and Cala Health just hopped on the fast track with their latest launch—the Cala kIQ Plus System. This bad boy is aiming to offer relief for those grappling with hand tremors, thanks to its FDA clearance and a host of new features. It's the first of its kind, combining multiple therapy modes with an...

Continue Reading
Community Banks Missing $106B Lending Opportunity?

Updated Category News Views 28

A Missed Opportunity for Community Banks It's a classic tale: community banks sleepwalking while big players snatch up low-hanging fruit right in their own backyards. According to the latest report by Cornerstone Advisors, commissioned by Teslar Software, these banks are essentially leaving $106 billion on the table when it comes to consumer lending. That's not just chump...

Continue Reading
NYSE Texas Redefines the U.S. Capital Markets Landscape

Updated Category News Views 21

NYSE Texas: Carving a Niche The notion of 'Y'all Street' might seem like a gimmick, but NYSE Texas is pushing a serious agenda with its newly released white paper, 'NYSE Texas and the Reshaping of U.S. Capital Markets.' This is no small feat. Texas is already housing 235 NYSE-listed companies, boasting a colossal combined worth of $4.8 trillion. With 130 of these firms...

Continue Reading
Dentistry.One Achieves HITRUST i1, Boosts Cybertrust

Updated Category News Views 21

HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...

Continue Reading
Purina Institute Highlights Nutritional Science at WSAVA 2026

Updated Category News Views 19

A Global Stage for Pet Nutrition Science The folks over at the Purina Institute are back in the spotlight as they gear up to throw their weight behind the 51st World Small Animal Veterinary Association (WSAVA) Congress in Warsaw, Poland. Set for October 13-15, 2026, this isn’t just another event—they're bringing some serious clout with their 'Food for Thought'...

Continue Reading
IWP and VYRE Unveil 'The Plug' for VBNGtv Content

Updated Category News Views 20

Bringing Capital and Content Under One Roof There's something in the air as Itibari-Waynne & Partners (IWP) team up with the VYRE Network to crank out a fresh slate of content for VYRE Business News Global (VBNGtv). This partnership ain't just another splash in the buzzy world of digital media; it's like merging Wall Street with Hollywood. IWP, prepping to go full...

Continue Reading
Northern Jet Names Veteran Matthew Harris as CEO

Updated Category News Views 33

Fresh Leadership at Northern Jet Well, if you didn’t see this coming, you’ve been snoozing on the tarmac. Northern Jet, no stranger to the skies after three decades, just roped in Matthew Harris as their new CEO from October 2, 2026. They're pulling in this hotshot with more than 25 years riding the turbulence of private aviation. And listen to this: his marching...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Groundbreaking for New Community by Century Communities

Updated Category News Views 191

Century Communities Breaks Ground on New Development Century Communities, Inc. (NYSE: CCS) has recently made headlines with the groundbreaking of its newest venture: a magnificent 318-acre community named Mirabella. This family-friendly location promises to provide over 1,000 new homes designed for affordability and comfort. Situated within the bustling west metro area of...

Continue Reading
Perseus Group Enhances Manufacturing Software with OptiVision

Updated Category News Views 105

Perseus Group Strengthens Its Position in the Industry Perseus Group, a dynamic operating group within Constellation Software Inc., has taken a significant step in enhancing its offerings in the pulp and paper sector. They recently announced the completion of an exciting acquisition that will support their growth strategy. The group has secured the exclusive global...

Continue Reading
Embrace Pet Insurance Breaks Records in Volunteerism and Giving

Updated Category News Views 267

Embrace Pet Insurance Partners in Charity and Volunteerism Despite facing economic hurdles, charitable contributions across the nation showed remarkable resilience, highlighting the generosity of individuals and businesses alike. Recent reports reveal that charitable donations in the U.S. hit staggering heights, exceeding $557 billion in the last reporting year. Embrace...

Continue Reading
Biocon Biologics Achieves Key FDA Approval for Jobevne™ in Oncology

Updated Category News Views 173

Biocon Biologics Secures FDA Approval for Jobevne™ Biocon Biologics Ltd, a subsidiary of Biocon Ltd, has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting approval for Jobevne™ (bevacizumab-nwgd). This biosimilar to the well-known Avastin (bevacizumab) is designed for intravenous use and aims to treat various types of cancer....

Continue Reading